Making the discoveries that defeat cancer

  • Home »
  • Research »
  • Repository

  • Administrators Login

  • Repository Homepage
  • About the Repository
  • Browse the Repository
  • Search the Repository
  • Contribute an Article
  • Missing Publications
  • Repository Help

AR aberrations and resistance to abiraterone or enzalutamide

Tools
- Tools
+ Tools

Attard, G., Antonarakis, E. S. (2016) AR aberrations and resistance to abiraterone or enzalutamide. NATURE REVIEWS UROLOGY, 13 (12). pp. 697-698. ISSN 1759-4812

Full text not available from this repository.

Abstract

Resistance to abiraterone or enzalutamide is a major medical burden the duration of benefit is highly variable and cross-resistance often occurs when these two agents are given sequentially. Blood-based analysis of androgen receptor splice variants and AR copy number gain or mutations could enhance understanding of the mechanisms of resistance and improve management of patients with castration-resistant prostate cancer.

Item Type: Editorial
Authors (ICR Faculty only): Attard, Gert
All Authors: Attard, G., Antonarakis, E. S.
Additional Information: ISI Document Delivery No.: EE9SL Times Cited: 0 Cited Reference Count: 10 Attard, Gerhardt Antonarakis, Emmanuel S. 0 NATURE PUBLISHING GROUP NEW YORK NAT REV UROL
Research teams: ICR divisions > Molecular Pathology > Treatment Resistance
Depositing User: Barry Jenkins
Date Deposited: 10 Jan 2017 09:31
Last Modified: 10 Jan 2017 09:31
URI: http://publications.icr.ac.uk/id/eprint/15606

Actions (login required)

View Item View Item
The Royal Marsden - NHS foundation trust